Skip to content

Multicenter Prospective Observational Study Evaluating the Management of Heart Failure

Questionnaire-based Multicenter Prospective Observational Study Evaluating Patient Perception, Compliance and Adaptation in the Management of Heart Failure - ADAPTATION HF

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05180370
Acronym
ADAPTATION-HF
Enrollment
500
Registered
2022-01-06
Start date
2021-03-15
Completion date
2022-01-31
Last updated
2023-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, Questionnaire, ECHO, Prospective, Cross-Sectional

Brief summary

ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study.

Detailed description

ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study. Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF. In addition, Pittsburg Sleep Quality Index will be applied to all cases. In addition, clinical features of HF from the current file of the cases (NYHA, comorbid conditions, comorbid diseases, blood pressure, heart rate, last drugs used, latest biochemistry (BNP/NTproBNP if available), hematology test results, most recent ECG , most recent echocardiography, coronary angiography report, if available) will be recorded. No additional examination/procedure will be performed for the study, only the data of the examinations requested by the clinician in routine clinical practice will be entered. A total of 500 patients from 10 centers will be included in this study over a six-month period.

Interventions

OTHERQuestionnaies

Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF (presented in the appendix to this protocol). In addition, Pittsburg Sleep Quality Index will be applied to all cases.

Sponsors

Klinar CRO
CollaboratorOTHER
AstraZeneca Turkey
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Outpatient or inpatient diagnosed with Heart Failure at least 6 months ago * Male or female patient aged 18 and over * Signed written informed consent form

Exclusion criteria

* newly diagnosed heart failure * CRY requiring dialysis * Serious liver and lung disease * LVAD/heart transplantation * HF due to possible temporary cause (myocarditis, peripartum CMP in the first 6 months, takotsubo etc.)

Design outcomes

Primary

MeasureTime frameDescription
General Status of the patients6 monthsAt the end of the six-month recruitment period, demographic, symptoms, clinical follow-up status, disease information, treatment compliance, and awareness assessment will be performed on all included patients.

Secondary

MeasureTime frame
HF Percutaneous Intervention History & Operation History6 Months
Medications Used for HF6 Months
HF Risk Factors6 Months
HF ECHO Results6 Months
HF Laboratory Results6 Months
HF Comorbidities6 Months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026